Embecta (EMBC) Interest & Investment Income (2022 - 2026)
Embecta recorded quarterly Interest & Investment Income of -$22.6 million in Q1 2026, up 6.22% quarter-over-quarter from -$24.1 million in Q4 2025, and up 15.36% year-over-year from -$19.6 million in Q1 2025.
Embecta's Interest & Investment Income history runs 5 years deep, the most recent figure standing at -$22.6 million for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 15.36% year-over-year to -$22.6 million; the TTM figure through Mar 2026 stood at -$99.4 million (up 10.77% YoY), while the FY2025 annual figure was -$107.3 million, up 4.45% from the prior year.
- Interest & Investment Income came in at -$22.6 million for Q1 2026 at Embecta, up from -$24.1 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of -$4.9 million in Q1 2022 to a low of -$29.0 million in Q3 2024.
- A 5-year average of -$24.7 million and a median of -$26.7 million in 2025 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income tumbled 446.94% in 2023 and advanced 15.36% in 2026, its largest moves.
- Embecta's Interest & Investment Income stood at -$25.6 million in 2022, then slipped by 8.2% to -$27.7 million in 2023, then declined by 0.72% to -$27.9 million in 2024, then rose by 13.62% to -$24.1 million in 2025, then gained by 6.22% to -$22.6 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered -$22.6 million, -$24.1 million, and -$26.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 9.00 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 12.29 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 5.10 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | -62.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | - |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 3.91 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -66.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 3.64 Mn |
| 10 | Embecta | 197.17 Mn | 3.77 Mn | 127.80 Mn | -22.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.60 Mn |
| Dec 31, 2025 | -24.10 Mn |
| Sep 30, 2025 | -26.10 Mn |
| Jun 30, 2025 | -26.60 Mn |
| Mar 31, 2025 | -26.70 Mn |
| Dec 31, 2024 | -27.90 Mn |
| Sep 30, 2024 | -29.00 Mn |
| Jun 30, 2024 | -27.80 Mn |
| Mar 31, 2024 | -27.80 Mn |
| Dec 31, 2023 | -27.70 Mn |
| Sep 30, 2023 | -27.60 Mn |
| Jun 30, 2023 | -27.00 Mn |
| Mar 31, 2023 | -26.80 Mn |
| Dec 31, 2022 | -25.60 Mn |
| Sep 30, 2022 | -21.80 Mn |
| Jun 30, 2022 | -19.50 Mn |
| Mar 31, 2022 | -4.90 Mn |